Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design. | PLoS Pathog | 2026 | 41871159 | PubTator, text mining | PubMed |
| βA4-Crystallin Mutations Disrupt Structural Stability and Crystallin Interactions in Congenital Cataract Pathogenesis. | Invest Ophthalmol Vis Sci | 2026 | 41823501 | PubTator, text mining | PubMed |
| Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. | Drug Des Devel Ther | 2026 | 41783574 | PubTator, text mining | PubMed |
| CopperNostics-Here We Are Now, Entertain Us! | Pharmaceuticals (Basel) | 2026 | 41754861 | PubTator, text mining | PubMed |
| Social Representations of Blood Donation: A Qualitative Study in a Referral Hospital in Perú. | Health Sci Rep | 2026 | 41726297 | PubTator, text mining | PubMed |
| Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines. | Curr Allergy Asthma Rep | 2026 | 41712151 | PubTator, text mining | PubMed |
| Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging. | EJNMMI Radiopharm Chem | 2026 | 41701408 | PubTator, text mining | PubMed |
| Ochratoxin A drives hepatocellular carcinoma progression via GRPR-mediated activation of PLCβ/IP3R/Ca²⁺ and RPS15A/p53 pathways by regulating cancer cell fate. | Ecotoxicol Environ Saf | 2026 | 41653713 | PubTator, text mining | PubMed |
| Head-to-Head Comparison of mpMRI, PSMA, GRPR PET/CT, and PET/CT Plus MRI for Local Staging of Primary Prostate Cancer and Their Prognostic Value. | J Nucl Med | 2026 | 41611483 | PubTator, text mining | PubMed |
| Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer. | Cancer Innov | 2026 | 41555955 | PubTator, text mining | PubMed |
| Current and future perspectives on radioligand therapy in advanced prostate cancer. | Ther Adv Med Oncol | 2026 | 41536963 | PubTator, text mining | PubMed |
| Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review. | Int J Dermatol | 2026 | 41531005 | PubTator, text mining | PubMed |
| Diagnostic performance of gastrin-releasing peptide receptor-targeted positron-emission tomography in biochemically recurrent prostate cancer-a systematic review and meta-analysis. | Quant Imaging Med Surg | 2026 | 41522030 | PubTator, text mining | PubMed |
| Computational studies of target-specific radiopharmaceuticals for theranostics. | J Mol Graph Model | 2026 | 41483740 | PubTator, text mining | PubMed |
| Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma. | Clin Nucl Med | 2026 | 41363947 | PubTator, text mining | PubMed |
| Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. | J Nucl Med | 2026 | 41344852 | PubTator, text mining | PubMed |
| Dual-tracer PET/CT with [68Ga]Ga-PSMA-617 and [68Ga]Ga-RM26 improves early prediction of biochemical failure in prostate cancer: a prospective phase II trial. | Eur J Nucl Med Mol Imaging | 2026 | 41042333 | PubTator, text mining | PubMed |
| Heterotopic Pancreas Mimicking Gastrointestinal Stromal Tumor on 68 Ga-NOTA-RM26 PET/CT. | Clin Nucl Med | 2026 | 40902157 | PubTator, text mining | PubMed |
| Alloknesis: a severe form of itch. | Br J Dermatol | 2026 | 40884188 | PubTator, text mining | PubMed |
| Clinical trials in cancer theranostics with potential near-term impact on clinical practice. | Br J Radiol | 2026 | 39873742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=2